Literature DB >> 30371813

Gonadotropin-Releasing Hormone (GnRH) Agonists for Fertility Preservation: Is POEMS the Final Verse?

Bo Yu1, Nancy E Davidson2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2019        PMID： 30371813      PMCID： PMC6376902          DOI： 10.1093/jnci/djy188

Source DB:  PubMed          Journal:  J Natl Cancer Inst        ISSN： 0027-8874            Impact factor:   13.506


× No keyword cloud information.
  16 in total

1.  Cancer, pregnancy and fertility: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.

Authors:  F A Peccatori; H A Azim; R Orecchia; H J Hoekstra; N Pavlidis; V Kesic; G Pentheroudakis
Journal:  Ann Oncol       Date:  2013-06-27       Impact factor: 32.976

2.  Tailoring therapies--improving the management of early breast cancer: St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2015.

Authors:  A S Coates; E P Winer; A Goldhirsch; R D Gelber; M Gnant; M Piccart-Gebhart; B Thürlimann; H-J Senn
Journal:  Ann Oncol       Date:  2015-05-04       Impact factor: 32.976

3.  Ovarian Suppression With Triptorelin During Adjuvant Breast Cancer Chemotherapy and Long-term Ovarian Function, Pregnancies, and Disease-Free Survival: A Randomized Clinical Trial.

Authors:  Matteo Lambertini; Luca Boni; Andrea Michelotti; Teresa Gamucci; Tiziana Scotto; Stefania Gori; Monica Giordano; Ornella Garrone; Alessia Levaggi; Francesca Poggio; Sara Giraudi; Claudia Bighin; Carlo Vecchio; Mario Roberto Sertoli; Paolo Pronzato; Lucia Del Mastro
Journal:  JAMA       Date:  2015 Dec 22-29       Impact factor: 56.272

4.  Second international consensus guidelines for breast cancer in young women (BCY2).

Authors:  Shani Paluch-Shimon; Olivia Pagani; Ann H Partridge; Eran Bar-Meir; Lesley Fallowfield; Deborah Fenlon; Eitan Friedman; Karen Gelmon; Oreste Gentilini; James Geraghty; Nadia Harbeck; Stephen Higgins; Sibylle Loibl; Elizabeth Moser; Fedro Peccatori; Hila Raanani; Bella Kaufman; Fatima Cardoso
Journal:  Breast       Date:  2016-02-06       Impact factor: 4.380

5.  Goserelin for ovarian protection during breast-cancer adjuvant chemotherapy.

Authors:  Halle C F Moore; Joseph M Unger; Kelly-Anne Phillips; Frances Boyle; Erika Hitre; David Porter; Prudence A Francis; Lori J Goldstein; Henry L Gomez; Carlos S Vallejos; Ann H Partridge; Shaker R Dakhil; Agustin A Garcia; Julie Gralow; Janine M Lombard; John F Forbes; Silvana Martino; William E Barlow; Carol J Fabian; Lori Minasian; Frank L Meyskens; Richard D Gelber; Gabriel N Hortobagyi; Kathy S Albain
Journal:  N Engl J Med       Date:  2015-03-05       Impact factor: 91.245

6.  Effect of luteinizing hormone-releasing hormone agonist on ovarian function after modern adjuvant breast cancer chemotherapy: the GBG 37 ZORO study.

Authors:  Bernd Gerber; Gunter von Minckwitz; Heinrich Stehle; Toralf Reimer; Ricardo Felberbaum; Nikolai Maass; Dorothea Fischer; Harald L Sommer; Bettina Conrad; Olaf Ortmann; Tanja Fehm; Mahdi Rezai; Keyur Mehta; Sibylle Loibl
Journal:  J Clin Oncol       Date:  2011-05-02       Impact factor: 44.544

7.  Randomized trial using gonadotropin-releasing hormone agonist triptorelin for the preservation of ovarian function during (neo)adjuvant chemotherapy for breast cancer.

Authors:  Pamela N Munster; Amy P Moore; Roohi Ismail-Khan; Charles E Cox; Mensura Lacevic; Margaret Gross-King; Ping Xu; W Bradford Carter; Susan E Minton
Journal:  J Clin Oncol       Date:  2012-01-09       Impact factor: 44.544

8.  Gonadatrophin suppression to prevent chemotherapy-induced ovarian damage: a randomized controlled trial.

Authors:  Eman A Elgindy; Dahlia O El-Haieg; Ola M Khorshid; Eman I Ismail; Mohamed Abdelgawad; Hassan N Sallam; Ahmed M Abou-Setta
Journal:  Obstet Gynecol       Date:  2013-01       Impact factor: 7.661

9.  No Evidence for the Benefit of Gonadotropin-Releasing Hormone Agonist in Preserving Ovarian Function and Fertility in Lymphoma Survivors Treated With Chemotherapy: Final Long-Term Report of a Prospective Randomized Trial.

Authors:  Isabelle Demeestere; Pauline Brice; Fedro A Peccatori; Alain Kentos; Jehan Dupuis; Pierre Zachee; Olivier Casasnovas; Eric Van Den Neste; Julie Dechene; Viviane De Maertelaer; Dominique Bron; Yvon Englert
Journal:  J Clin Oncol       Date:  2016-05-23       Impact factor: 44.544

10.  Cancer and fertility preservation: international recommendations from an expert meeting.

Authors:  Matteo Lambertini; Lucia Del Mastro; Maria C Pescio; Claus Y Andersen; Hatem A Azim; Fedro A Peccatori; Mauro Costa; Alberto Revelli; Francesca Salvagno; Alessandra Gennari; Filippo M Ubaldi; Giovanni B La Sala; Cristofaro De Stefano; W Hamish Wallace; Ann H Partridge; Paola Anserini
Journal:  BMC Med       Date:  2016-01-04       Impact factor: 8.775
View more
  1 in total

1.  Severe ovarian hyperstimulation syndrome associated with long-acting GnRH agonist in oncofertility patients.

Authors:  Jacob Christ; Christopher N Herndon; Bo Yu
Journal:  J Assist Reprod Genet       Date:  2021-01-20       Impact factor: 3.412
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.